Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiling Yang

Showing results (81-90 of 156) with videos related to

Pageof 16
Sort By:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|February 2, 2019
[Sevoflurane inhalation sedation could shorten the duration of endotracheal intubation and the total length of hospital stay of critical patients after surgery as compared with propofol intravenous sedation: a Meta-analysis of 537 patients]Yanqi Wu, Yahui Wang, Feng Shen, et al.
Cell Cycle (Georgetown, Tex.)|March 1, 2012
MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTENChangju Qu, Zhihui Liang, JiaLing Huang, et al.
Oncology Reports|January 22, 2015
Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinomaTao Xu, Bojin Su, Chunhua Wang, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2014
Novel, sulfonamide linked inhibitors of the hepatitis C virus NS3 proteaseThorsten A Kirschberg, Neil H Squires, Huiling Yang, et al.
Biochimica Et Biophysica Acta|August 21, 2014
Binding kinetics, potency, and selectivity of the hepatitis C virus NS3 protease inhibitors GS-9256 and vedroprevirOna Barauskas, Amoreena C Corsa, Ruth Wang, et al.
Medical Oncology (Northwood, London, England)|September 4, 2014
Prognostic significance of circulating CD19+ B lymphocytes in EBV-associated nasopharyngeal carcinomaTao Xu, Zheli Huang, Bojin Su, et al.
Journal of Cellular and Molecular Medicine|July 1, 2014
Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancersZhen Liu, Chunping Mai, Huiling Yang, et al.
Cell Death & Disease|June 18, 2025
N6-methyladenosine-modified GPX2 impacts cancer cell stemness and TKI resistance through regulating of redox metabolismXu Yang, Long Yu, Miaomiao Shao, et al.
Molecules (Basel, Switzerland)|January 8, 2023
The Effective Treatment of Purpurin on Inflammation and Adjuvant-Induced ArthritisWeiya Zeng, Caihong Shen, Suifen Mo, et al.
Acta Biochimica Et Biophysica Sinica|May 4, 2012
Overexpressed DNA-binding protein inhibitor 2 as an unfavorable prognosis factor promotes cell proliferation in nasopharyngeal carcinomaZhen Liu, Jing Chen, Weiren Luo, et al.
Pageof 16

Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|February 2, 2019
[Sevoflurane inhalation sedation could shorten the duration of endotracheal intubation and the total length of hospital stay of critical patients after surgery as compared with propofol intravenous sedation: a Meta-analysis of 537 patients]Yanqi Wu, Yahui Wang, Feng Shen, et al.
Cell Cycle (Georgetown, Tex.)|March 1, 2012
MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTENChangju Qu, Zhihui Liang, JiaLing Huang, et al.
Oncology Reports|January 22, 2015
Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinomaTao Xu, Bojin Su, Chunhua Wang, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2014
Novel, sulfonamide linked inhibitors of the hepatitis C virus NS3 proteaseThorsten A Kirschberg, Neil H Squires, Huiling Yang, et al.
Biochimica Et Biophysica Acta|August 21, 2014
Binding kinetics, potency, and selectivity of the hepatitis C virus NS3 protease inhibitors GS-9256 and vedroprevirOna Barauskas, Amoreena C Corsa, Ruth Wang, et al.
Medical Oncology (Northwood, London, England)|September 4, 2014
Prognostic significance of circulating CD19+ B lymphocytes in EBV-associated nasopharyngeal carcinomaTao Xu, Zheli Huang, Bojin Su, et al.
Journal of Cellular and Molecular Medicine|July 1, 2014
Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancersZhen Liu, Chunping Mai, Huiling Yang, et al.
Cell Death & Disease|June 18, 2025
N6-methyladenosine-modified GPX2 impacts cancer cell stemness and TKI resistance through regulating of redox metabolismXu Yang, Long Yu, Miaomiao Shao, et al.
Molecules (Basel, Switzerland)|January 8, 2023
The Effective Treatment of Purpurin on Inflammation and Adjuvant-Induced ArthritisWeiya Zeng, Caihong Shen, Suifen Mo, et al.
Acta Biochimica Et Biophysica Sinica|May 4, 2012
Overexpressed DNA-binding protein inhibitor 2 as an unfavorable prognosis factor promotes cell proliferation in nasopharyngeal carcinomaZhen Liu, Jing Chen, Weiren Luo, et al.
Pageof 16